Bjarne Udd

5.6k total citations
91 papers, 2.8k citations indexed

About

Bjarne Udd is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bjarne Udd has authored 91 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 47 papers in Cardiology and Cardiovascular Medicine and 39 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bjarne Udd's work include Cardiomyopathy and Myosin Studies (46 papers), Muscle Physiology and Disorders (43 papers) and Genetic Neurodegenerative Diseases (37 papers). Bjarne Udd is often cited by papers focused on Cardiomyopathy and Myosin Studies (46 papers), Muscle Physiology and Disorders (43 papers) and Genetic Neurodegenerative Diseases (37 papers). Bjarne Udd collaborates with scholars based in Finland, United States and France. Bjarne Udd's co-authors include Ralf Krahe, Peter Hackman, Anna Vihola, G. Meola, J. Sarparanta, Linda L. Bachinski, Isabelle Richard, Tiina Suominen, Henna Haravuori and Richard T. Moxley and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.

In The Last Decade

Bjarne Udd

87 papers receiving 2.8k citations

Peers

Bjarne Udd
Sita Reddy United States
Nigel F. Clarke Australia
Aleksey Shatunov United Kingdom
Julia Rankin United Kingdom
Melinda L. Moseley United States
Bjarne Udd
Citations per year, relative to Bjarne Udd Bjarne Udd (= 1×) peers Montse Olivé

Countries citing papers authored by Bjarne Udd

Since Specialization
Citations

This map shows the geographic impact of Bjarne Udd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjarne Udd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjarne Udd more than expected).

Fields of papers citing papers by Bjarne Udd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjarne Udd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjarne Udd. The network helps show where Bjarne Udd may publish in the future.

Co-authorship network of co-authors of Bjarne Udd

This figure shows the co-authorship network connecting the top 25 collaborators of Bjarne Udd. A scholar is included among the top collaborators of Bjarne Udd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjarne Udd. Bjarne Udd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Božović, Ivana Babič, Annalaura Torella, Mridul Johari, et al.. (2025). Gene prioritisation for enhancing molecular diagnosis in rare skeletal muscle disease cohort. Journal of Medical Genetics. 62(5). 350–357. 1 indexed citations
2.
Spinazzi, Marco, Marco Savarese, Franck Letournel, et al.. (2025). Myotilin gene duplication causing late‐onset myotilinopathy. European Journal of Neurology. 32(1). e70029–e70029. 1 indexed citations
3.
Claeys, Kristl G., Marco Savarese, Per Harald Jonson, et al.. (2024). A Titin Truncating Variant Causing a Dominant Myopathy With Cardiac Involvement in a Large Family. Neurology Genetics. 10(5). e200185–e200185.
4.
Jokela, Manu, Meriel McEntagart, Tessa Homfray, et al.. (2023). The crucial role of titin in fetal development: recurrent miscarriages and bone, heart and muscle anomalies characterise the severe end of titinopathies spectrum. Journal of Medical Genetics. 60(9). 866–873. 8 indexed citations
5.
Savarese, Marco, et al.. (2023). Long‐term favorable prognosis in late onset dominant distal titinopathy: Tibial muscular dystrophy. European Journal of Neurology. 30(4). 1080–1088. 2 indexed citations
6.
Savarese, Marco, Susanne Rinné, Anne Schänzer, et al.. (2023). Differential effects of mutations of POPDC proteins on heteromeric interaction and membrane trafficking. Acta Neuropathologica Communications. 11(1). 4–4. 4 indexed citations
7.
Sarparanta, J., Per Harald Jonson, Jens Reimann, et al.. (2023). Extension of the DNAJB2a isoform in a dominant neuromyopathy family. Human Molecular Genetics. 32(21). 3029–3039. 4 indexed citations
8.
Olivé, Montse, Cristina Domínguez‐González, Mridul Johari, et al.. (2022). Mutation update for the ACTN2 gene. Human Mutation. 43(12). 1745–1756. 15 indexed citations
9.
Savarese, Marco, Anna Vihola, Manu Jokela, et al.. (2021). Out-of-Frame Mutations in ACTN2 Last Exon Cause a Dominant Distal Myopathy With Facial Weakness. Neurology Genetics. 7(5). e619–e619. 7 indexed citations
10.
Salih, Mustafa A., Muddathir H. Hamad, Marco Savarese, et al.. (2021). Exome Sequencing Reveals Novel TTN Variants in Saudi Patients with Congenital Titinopathies. Genetic Testing and Molecular Biomarkers. 25(12). 757–764. 5 indexed citations
11.
Jokela, Manu, Giorgio Tasca, Anna Vihola, et al.. (2019). An unusual ryanodine receptor 1 (RYR1) phenotype. Neurology. 92(14). e1600–e1609. 12 indexed citations
12.
Sellier, Chantal, Estefanía Cerro-Herreros, Markus Blatter, et al.. (2018). rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences. Nature Communications. 9(1). 2009–2009. 57 indexed citations
13.
Huovinen, Sanna, Sini Penttilä, Panu Somervuo, et al.. (2015). Differential Isoform Expression and Selective Muscle Involvement in Muscular Dystrophies. American Journal Of Pathology. 185(10). 2833–2842. 10 indexed citations
14.
Tasca, Giorgio, Zagaa Odgerel, Mauro Monforte, et al.. (2012). Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late‐onset cerebellar ataxia. Muscle & Nerve. 46(2). 275–282. 22 indexed citations
15.
Raheem, Olayinka, Shodimu-Emmanuel Olufemi, Linda L. Bachinski, et al.. (2010). Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2. American Journal Of Pathology. 177(6). 3025–3036. 61 indexed citations
16.
Udd, Bjarne. (2009). 165th ENMC International Workshop: Distal myopathies 6–8th February 2009 Naarden, The Netherlands. Neuromuscular Disorders. 19(6). 429–438. 30 indexed citations
17.
Vihola, Anna, Mario Sirito, Linda L. Bachinski, et al.. (2007). G.P.14.14 Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1). Neuromuscular Disorders. 17(9-10). 858–858. 1 indexed citations
18.
Béhin, Anthony, Thierry Maisonobe, Bjarne Udd, & B. Eymard. (2007). C.P.4.05 Zaspopathy as a cause of asymmetrical, predominantly distal vacuolar myopathy. Neuromuscular Disorders. 17(9-10). 879–880. 1 indexed citations
19.
Udd, Bjarne, Vesa Juvonen, Peter M. Andersen, et al.. (2001). Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world. European Journal of Human Genetics. 9(6). 431–436. 32 indexed citations
20.
Drugge, Ulf, Gösta Holmgren, & Bjarne Udd. (1992). The First Case of Familial Amyloidotic Polyneuropathy (FAP Met30) in the Finnish Population. Human Heredity. 42(3). 184–188. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026